Human trophoblast stem cells and use thereof
View Patent ↗Existence of human trophoblast stem (hTS) cells has been suspected but unproved. The isolation of hTS cells is reported in the early stage of chorionic villi by expressions of FGF4, FGFR-2, Oct4, Thy-1, and stage-specific embryonic antigens distributed in different compartments of the cell. hTS cells are able to derive into specific cell phenotypes of the three primitive embryonic layers, produce chimeric reactions in mice, and retain a normal karyotype and telomere length. In hTS cells, Oct4 and fgfr-2 expressions can be knockdown by bFGF. These facts suggest that differentiation of the hTS cells play an important role in implantation and placentation. hTS cells could be apply to human cell differentiation and for gene and cell-based therapies.
1. A method of differentiating an isolated human trophoblast stem cell, comprising:
exposing an isolated human trophoblast stem cell that expresses transcripts for OCT-4, SSEA-1, SSEA-3 and SSEA-4 to an induction medium,
thereby differentiating said stem cell into mesodermal cell.
2. The method of claim 1 , wherein said mesodermal cell is an osteoblast and the induction medium comprises dexamethasone, beta-glycerolphosphate and ascorbic acid.
3. The method of claim 1 , wherein said mesodermal cell is a myocyte and the induction medium comprises dexamethasone and hydrocortisone.
4. The method of claim 1 , wherein said mesodermal cell is a chondrocyte and the induction medium comprises insulin, TGF beta 1, and ascorbate-2-phosphate.
5. The method of claim 1 , wherein said mesodermal cell is an adipocyte and the induction medium comprises insulin, dexamethasone, isobutyl methylxanthine, and indomethacin.
6. A method of differentiating an isolated human trophoblast stem cell into a cell that produces insulin, the method comprising:
contacting said human trophoblast stem cell with a medium comprising glucose, beta-mercaptoethanol, and nicotinamide, thereby differentiating said stem cell into a cell that produces insulin,
wherein said human trophoblast stem cell expresses transcripts for SSEA-1, SSEA-3, SSEA-4 and Oct-4, and wherein said human trophoblast stem cell is isolated from human trophoblast tissue.
7. The method of claim 6 , wherein said stem cell is transfected with an expression vector.
8. A method of differentiating an isolated human trophoblast stem cell in vitro, comprising:
exposing an isolated human trophoblast stem cell that expresses transcripts for OCT-4, SSEA-1, SSEA-3 and SSEA-4 to an induction medium comprising all trans-retinoic acid, thereby differentiating said stem cell into a neural cell.